Last reviewed · How we verify
prifetrastat in combination with fulvestrant — Competitive Intelligence Brief
phase 2
Live · refreshed every 30 min
Target snapshot
prifetrastat in combination with fulvestrant (prifetrastat-in-combination-with-fulvestrant) — Pfizer Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| prifetrastat in combination with fulvestrant TARGET | prifetrastat-in-combination-with-fulvestrant | Pfizer Inc. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- prifetrastat in combination with fulvestrant CI watch — RSS
- prifetrastat in combination with fulvestrant CI watch — Atom
- prifetrastat in combination with fulvestrant CI watch — JSON
- prifetrastat in combination with fulvestrant alone — RSS
Cite this brief
Drug Landscape (2026). prifetrastat in combination with fulvestrant — Competitive Intelligence Brief. https://druglandscape.com/ci/prifetrastat-in-combination-with-fulvestrant. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab